Editas Medicine, Inc. (EDIT)
NASDAQ: EDIT · Real-Time Price · USD
2.375
-0.035 (-1.45%)
Nov 21, 2024, 2:01 PM EST - Market open

Editas Medicine Stock Forecast

Stock Price Forecast

The 13 analysts with 12-month price forecasts for Editas Medicine stock have an average target of 9.38, with a low estimate of 3.00 and a high estimate of 15. The average target predicts an increase of 294.95% from the current stock price of 2.38.

Analyst Consensus: Buy
Target Low Average Median High
Price $3.00 $9.38 $9.00 $15
Change +26.32% +294.95% +278.95% +531.58%

Analyst Ratings

The average analyst rating for EDIT stock from 13 stock analysts is "Buy". This means that analysts believe this stock is likely to outperform the market over the next twelve months.

Recommendation Trends

Rating Jun '24Jul '24Aug '24Sep '24Oct '24Nov '24
Strong Buy 444556
Buy 111011
Hold 666766
Sell 000000
Strong Sell 000000
Total 111111121213

Latest Forecasts

Analyst Firm Rating Rating Action Price Target Upside Date
Chardan Capital
Chardan Capital
Strong Buy
Maintains
$12
Strong Buy Maintains $12 +405.26% Nov 5, 2024
RBC Capital
RBC Capital
Hold
Maintains
$8$5
Hold Maintains $8$5 +110.53% Nov 5, 2024
Stifel
Stifel
Strong Buy
Maintains
$17$11
Strong Buy Maintains $17$11 +363.16% Nov 5, 2024
Truist Securities
Truist Securities
Strong Buy
Maintains
$12$8
Strong Buy Maintains $12$8 +236.84% Nov 5, 2024
Wells Fargo
Wells Fargo
Buy
Maintains
$9$7
Buy Maintains $9$7 +194.74% Nov 5, 2024
More Analyst Ratings

Financial Forecast

Revenue This Year
35.23M
from 78.12M
Decreased by -54.91%
Revenue Next Year
14.91M
from 35.23M
Decreased by -57.67%
EPS This Year
-2.81
from -2.02
EPS Next Year
-2.42
from -2.81
Fiscal Year FY 2019 FY 2020 FY 2021 FY 2022 FY 2023 FY 2024 FY 2025 FY 2026
Period Ending Dec 31, 2019 Dec 31, 2020 Dec 31, 2021 Dec 31, 2022 Dec 31, 2023 Dec 31, 2024 Dec 31, 2025 Dec 31, 2026
Revenue
20.53M90.73M25.54M19.71M78.12M35.23M14.91M26.18M
Revenue Growth
-35.71%341.93%-71.85%-22.83%296.32%-54.91%-57.67%75.55%
EPS
-2.68-1.98-2.85-3.21-2.02-2.81-2.42-2.34
EPS Growth
--------
Forward PE
--------
No. Analysts -----212017
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

Revenue 20242025202620272028
High 76.0M 38.9M 89.0M
Avg 35.2M 14.9M 26.2M
Low 1.8M n/a n/a

Revenue Growth

Revenue Growth 20242025202620272028
High
-2.7%
10.3%
497.0%
Avg
-54.9%
-57.7%
75.6%
Low
-97.7%
- -

EPS Forecast

EPS 20242025202620272028
High -2.44 -0.42 -1.08
Avg -2.81 -2.42 -2.34
Low -3.27 -3.24 -3.82

EPS Growth

EPS Growth 20242025202620272028
High - - -
Avg - - -
Low - - -
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.